References

  1. Canadian Hemophilia Society. All about von Willebrand disease…for people with von Willebrand disease and their families. 3rd ed. http://www.hemophilia.ca/files/All%20About%20VWD%202011%20-%20FINAL.pdf. Published December 2011. Accessed May 16, 2016.
  2. Centers for Disease Control and Prevention. Facts about von Willebrand disease. http://www.cdc.gov/ncbddd/vWd/facts.html. Updated March 2, 2016. Accessed May 16, 2016.
  3. The Lewin Group. NHF Summit on von Willebrand disease. November 21, 2014.
  4. VONVENDI Prescribing Information.
  5. Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 2014;25:206-216.
  6. Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171-232.
  7. Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046.